Velgret Healthcare

LIZO-M Tablets (Montelukast Sodium & Levocetirizine Hydrochloride Tablets I.P.) are a clinically effective combination therapy designed to provide comprehensive relief from allergic and respiratory conditions. Each tablet combines Montelukast Sodium, a leukotriene receptor antagonist, with Levocetirizine Hydrochloride, a modern, non-sedating antihistamine, working together to control both early and late-phase allergic responses.

LIZO-M is widely prescribed for the management of allergic rhinitis, seasonal and perennial allergies, sneezing, runny nose, nasal congestion, itchy and watery eyes, and allergy-related cough. Montelukast helps reduce airway inflammation and prevents bronchoconstriction, making it beneficial in allergy-associated asthma and wheezing, while Levocetirizine provides fast and long-lasting relief from histamine-mediated symptoms without causing significant drowsiness.

Manufactured under stringent GMP quality standards, LIZO-M ensures high purity, safety, and consistent therapeutic performance. The tablets are easy to swallow and suitable for once-daily dosing, improving patient compliance and treatment outcomes.

Backed by Velgret Healthcare, LIZO-M is a reliable choice for physicians, distributors, and PCD pharma partners seeking a trusted anti-allergic formulation with proven efficacy and strong market acceptance. Its balanced composition, attractive packaging, and competitive positioning make LIZO-M an ideal solution for effective allergy control and improved respiratory comfort.

Dosage: As directed by the physician.

LIZO-M KID Tablets (Montelukast & Levocetirizine Dispersible Tablets) are specially designed to provide safe, effective, and gentle relief from allergic and respiratory conditions in children. This pediatric formulation combines Montelukast, a leukotriene receptor antagonist, with Levocetirizine, a modern antihistamine, offering dual-action control of allergy symptoms.

LIZO-M KID is commonly prescribed for allergic rhinitis, seasonal allergies, sneezing, runny or blocked nose, itchy and watery eyes, skin allergies, and allergy-related cough in children. Montelukast helps reduce airway inflammation and prevents allergy-induced wheezing, while Levocetirizine provides fast and long-lasting relief from histamine-mediated symptoms such as itching and sneezing with minimal sedation.

The dispersible tablet format allows the tablet to dissolve easily in water or be taken directly on the tongue, making it highly convenient for children who have difficulty swallowing tablets. Manufactured under strict GMP quality standards, LIZO-M KID ensures accurate dosing, high safety, and consistent therapeutic efficacy.

Presented by Velgret Healthcare, LIZO-M KID Tablets are a trusted choice for pediatricians and pharma partners looking for a reliable pediatric anti-allergic medicine. With child-friendly dosage, attractive packaging, and proven effectiveness, LIZO-M KID supports better breathing, improved comfort, and an active, healthy childhood.

Dosage: As directed by the pediatrician.